Skip to content
The Policy VaultThe Policy Vault

Generic topical retinoidsBlue Cross Blue Shield of New Mexico

Treatment of acne vulgaris

Initial criteria

  • The patient is not using the requested agent for treatment of wrinkles, stretch marks, age spots, or skin lightening
  • Additional approval pathway:
  • 1. Member resides in Ohio AND
  • 2. Plan is Fully Insured or HIM Shop (SG) AND BOTH of the following:
  • A. Patient has no FDA labeled contraindications to the requested agent AND
  • B. ONE of the following:
  • 1. Patient has another FDA labeled indication for the requested agent and route OR
  • 2. Indication is supported in compendia for the requested agent and route OR
  • 3. Prescriber provides two major peer-reviewed journal articles supporting proposed use (accepted study designs include randomized, double-blind, placebo-controlled clinical trials; case studies not acceptable)

Approval duration

12 months